You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

Investigational Drug Information for Paltusotine


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Paltusotine?

Paltusotine is an investigational drug.

There have been 6 clinical trials for Paltusotine. The most recent clinical trial was a Phase 2 trial, which was initiated on December 17th 2021.

The most common disease conditions in clinical trials are Acromegaly, Malignant Carcinoid Syndrome, and Diarrhea. The leading clinical trial sponsors are Crinetics Pharmaceuticals Inc. and [disabled in preview].

There are two US patents protecting this investigational drug and twenty-eight international patents.

Recent Clinical Trials for Paltusotine
TitleSponsorPhase
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeCrinetics Pharmaceuticals Inc.Phase 2
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)Crinetics Pharmaceuticals Inc.Phase 3
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of AcromegalyCrinetics Pharmaceuticals Inc.Phase 3

See all Paltusotine clinical trials

Clinical Trial Summary for Paltusotine

Top disease conditions for Paltusotine
Top clinical trial sponsors for Paltusotine

See all Paltusotine clinical trials

US Patents for Paltusotine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Paltusotine ⤷  Sign Up Somatostatin modulators and uses thereof CRINETICS PHARMACEUTICALS, INC. (San Diego, CA) ⤷  Sign Up
Paltusotine ⤷  Sign Up Somatostatin modulators and uses thereof CRINETICS PHARMACEUTICALS, INC. (San Diego, CA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Paltusotine

Drugname Country Document Number Estimated Expiration Related US Patent
Paltusotine Australia AU2017296392 2036-07-14 ⤷  Sign Up
Paltusotine Australia AU2020277122 2036-07-14 ⤷  Sign Up
Paltusotine Brazil BR112019000692 2036-07-14 ⤷  Sign Up
Paltusotine Canada CA3030423 2036-07-14 ⤷  Sign Up
Paltusotine China CN109715612 2036-07-14 ⤷  Sign Up
Paltusotine China CN115557929 2036-07-14 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.